SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹31 Cr | ₹30 Cr | ₹2.65 Cr | ₹0.73 Cr |
What is the latest Total Non-Current Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹30 Cr |
| Mar2020 | ₹2.65 Cr |
| Mar2019 | ₹0.73 Cr |
How is Total Non-Current Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 1.48 | |
| Mar2024 | ₹30 Cr | 1,037.96 | |
| Mar2020 | ₹2.65 Cr | 264.01 | |
| Mar2019 | ₹0.73 Cr | - | |
Compare Total Non-Current Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹710.1 Cr | 10.1% | 9.4% | -23.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 10.1% |
9.4% |
-23.9% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses